1 / 15

European Best Practice Guidelines

European Best Practice Guidelines. James Tattersall. Background. Process commissioned by EDTA-ERA in 1998 KDOQI, CARI, UK renal guidelines already published Considerable guideline activity underway “Expert groups” Transplant (2000, 2002) HD (2002, 2007) PD (2005) Anaemia (1999, 2005).

niveditha
Télécharger la présentation

European Best Practice Guidelines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. European Best Practice Guidelines James Tattersall

  2. Background • Process commissioned by EDTA-ERA in 1998 • KDOQI, CARI, UK renal guidelines already published • Considerable guideline activity underway • “Expert groups” • Transplant (2000, 2002) • HD (2002, 2007) • PD (2005) • Anaemia (1999, 2005)

  3. Co-operative initiatives • K/DOQI • Bone metabolism 2004 • Hypertension in CKD 2004 • CVD in dialysis 2005 • Anemia 2006 • KDIGO • Classification/ definition CKD • Hep C • Bone/mineral metabolism

  4. Organisation facilitating guidelines • Logistical and secretarial • Baxter • Fresenius • Hoffman-La Roche, Amgen, Vifor, Ortho-Biotech • Literature search and evidence grading • Cochrane (HD) • Thomson Gardiner-Caldwell (Anaemia) • Collection of feedback and dissemination of guidelines • EDTA-ERA

  5. Funding sources • Baxter (PD) • Fresenius (HD) • Hoffman-La Roche (Transplant, Anaemia) • Amgen (Anaemia) • Ortho Biotech (anaemia) • Vifor (anaemia)

  6. How guidelines relate to healthcare systems in area • Europe is diverse • 30 + countries • Mixture of models (socialised, insurance-based) • Mixture of languages. • Differences between levels in healthcare funding. • ‘New’ ex-soviet empire European countries inherited broken systems. • At least for dialysis, convergence was surprisingly rapid. • No attempt to include cost-benefit in the guidelines

  7. Selection and prioritisation of guideline topics • No formal process • Decided by the expert groups (HD, PD, Transplant) • Composition of group • Existing guidelines • Availability of evidence • Considered to be important

  8. Selection of expert groups • Invited by the ERA-EDTA council. • No formal selection process • European experts on the guideline topic • No more than 1-2 per country in each group. • Initially only nephrologists • HD group invited one dietician, one radiologist and one surgeon for 2nd part.

  9. Methodology • Delegated to expert groups. • Division into sub-groups (3-4 members) • Formulation of important questions • Generation of key words • Literature search performed by Cochrane • All literature graded by Cochrane • All literature scored by expert group. • Each paper scored by at least 2 members. • Modified READER system (with elements of GRADE) used to score papers.

  10. Methodology (2) • Randomly selected papers presented to group and the scores challenged by whole group. • Low-scoring papers automatically rejected • Reader score includes relevancy. • Rejected papers retained as part of the guideline audit. • Guidelines formulated by sub-groups. • Guidelines presented and circulated to entire group. • All guidelines signed-off by each group member.

  11. Methodology (3) • External expert reviewers selected • Non-nephrologists • Non-European • Draft guidelines submitted to • Reviewers • ERA-EDTA membership • Selected international nephrology societies (ISN, ASN, CSN, CARI) • All European national associations.

  12. Disseminations and implementation • Draft guidelines, responses and proposed amendments presented at ERA-EDTA conference 2006 • Final versions published 2007 • Published in NDT • ERA-EDTA website • Impact to be assessed by QUEST projects. • Adequacy of HD

  13. strengths • Formal, independent selection of evidence. • Formal, transparent scoring of papers. • Consultation at late stages • Ongoing study to assess impact (QUEST) weaknesses • Commercial funding • Qualification/selection of expert groups. • No patient, manager or nurse representation. • Inconsistent style, format, terminology • No consideration of guideline lifecycle • No consultation at early stage • Prioritisation • Questions asked • What the guidelines are trying to achieve not clearly stated.

  14. Future outlook • ERA-EDTA have a responsibility to maintain, update, withdraw or correct existing guidelines. • Impact of existing guidelines to be monitored by QUEST • ERA-EDTA council have decided that the Association should remain involved in new guideline development. • The form of this involvement has not yet been decided. • First EBPG meeting January 2008

More Related